Healthcare - Biotechnology - NASDAQ - CA
$ 0.2799
55.5 %
$ 4.61 M
Market Cap
None
P/E
INCOME STATEMENT
0
REVENUE
-4.79 M
OPERATING INCOME
-4.93 M
NET INCOME
EFFICIENCY
Earnings Waterfall
BriaCell Therapeutics Corp.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 33.3 M |
| Operating Income | -4.79 M |
| Other Expenses | 140 K |
| Net Income | -4.93 M |
Income Statement
Millions
| Jul-2024 | Jul-2023 | Jul-2022 | Jul-2021 | Jul-2020 | Jul-2019 | Jul-2018 | Jul-2017 | Jul-2016 | Jul-2015 | Jul-2014 | Jul-2013 | Jul-2012 | Jul-2011 | Jul-2010 | Jul-2009 | Jul-2008 | Jul-2007 | Jul-2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||||||||||||||
| Cost Of Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| OPERATING INCOME | |||||||||||||||||||
| Operating Expenses | 33.3 | 23.3 | 3.39 K | (3.7) | (1.4) | (0.9) | (1.1) | 0 | 1.7 | 1.4 | 0.4 | 0.4 | 0.6 | 1.1 | 0.3 | 0.2 | 0.1 | 0.1 | 8.58 K |
| Selling, General and Administrative Expenses | 6.2 | 7.9 | 7.3 | (3.7) | (1.4) | (0.9) | (1.1) | 0 | 0.9 | 1.3 | 0.4 | 0.4 | 0.6 | 1.1 | 0.3 | 0.2 | 0.1 | 0.1 | 8.58 K |
| Research and Development Expenses | 27.2 | 15.3 | 8.0 | 1.3 | 2.2 | 3.7 | 2.4 | 0 | 0.7 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | (4.8) | (23.3) | (15.3) | (7.0) | (3.6) | (4.7) | (3.8) | 0 | (1.7) | (1.4) | (0.4) | (0.4) | (1.2) | (1.1) | (0.3) | (0.2) | (0.1) | (0.1) | 8.58 K |
| PRE-TAX INCOME | |||||||||||||||||||
| Interest Income Expense | 0 | 0 | 979 | 46.1 K | 27 K | 23.8 K | 15.6 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | 0 | 3.0 | 3.7 | (6.8) | 85.1 K | 5.7 | 4.9 | 0 | 28.8 K | (1.2) | (7.7) | 55.6 K | 0.2 | 39 K | (0.6) | 2.33 K | 0 | 0 | 0 |
| Pre-Tax Income | (4.8) | (20.3) | (11.5) | 3.7 | 1.4 | 0.9 | 1.1 | 0 | (1.7) | (2.7) | (8.1) | (0.4) | (1.0) | (1.1) | (0.9) | (0.2) | 0 | 0 | 0 |
| NET INCOME | |||||||||||||||||||
| Tax Provision | 0 | (0.2) | 979 | 6.6 | 72.3 K | 0.3 | (0.3) | 0 | 29.2 K | 1.2 | 7.7 | 55.6 K | 0.4 | 25.6 K | 0.6 | 2.73 K | 98.9 K | 0.1 | 8.58 K |
| Net Income | (4.8) | (20.3) | (11.5) | 3.7 | 1.4 | 0.9 | 1.1 | 0 | (1.7) | (2.7) | (8.1) | (0.4) | (1.0) | (1.1) | (0.9) | (0.2) | 98.9 K | (0.1) | 8.58 K |
| EPS | 0.29 | 1.31 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |